We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$13.3B
AUM Growth
+$1.82B
Cap. Flow
+$65.9M
Cap. Flow %
0.5%
Top 10 Hldgs %
32.36%
Holding
350
New
21
Increased
125
Reduced
153
Closed
21

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$72.8M
2
ABBV icon
AbbVie
ABBV
+$59.8M
3
PG icon
Procter & Gamble
PG
+$53.3M
4
VZ icon
Verizon
VZ
+$26.4M
5
AVGO icon
Broadcom
AVGO
+$19.9M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$79.9M
2
MCD icon
McDonald's
MCD
+$64.5M
3
EL icon
Estee Lauder
EL
+$57.4M
4
O icon
Realty Income
O
+$20.5M
5
AAPL icon
Apple
AAPL
+$18.6M

Sector Composition

Rank Sector Weight
1 Technology 21.17%
2 Healthcare 15.36%
3 Financials 13.42%
4 Consumer Staples 9.92%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KNSL icon
151
Kinsale Capital Group
KNSL
$8.51B
$4.21M 0.03%
27,137
-466
-2% -$62K
MA icon
152
Mastercard
MA
$493B
$4.21M 0.03%
14,227
+1,712
+14% +$483K
GOOGL icon
153
Alphabet (Google) Class A
GOOGL
$4.33T
$4.04M 0.03%
56,940
-160
-0.3% -$10.8K
USPH icon
154
US Physical Therapy
USPH
$1.22B
$3.97M 0.03%
49,016
-38,544
-44% -$2.81M
SIMO icon
155
Silicon Motion
SIMO
$8.68B
$3.93M 0.03%
80,672
+677
+0.8% +$30K
HCKT icon
156
Hackett Group
HCKT
$287M
$3.92M 0.03%
289,198
-44,431
-13% -$613K
ISRG icon
157
Intuitive Surgical
ISRG
$134B
$3.79M 0.03%
19,938
-5,601
-22% -$1M
CARR icon
158
Carrier Global
CARR
$52.8B
$3.74M 0.03%
+168,515
New +$3.13M
FSS icon
159
Federal Signal
FSS
$7.83B
$3.71M 0.03%
124,922
-1,979
-2% -$56K
SSD icon
160
Simpson Manufacturing
SSD
$8.16B
$3.71M 0.03%
44,006
-4,582
-9% -$338K
CNMD icon
161
CONMED
CNMD
$1.47B
$3.66M 0.03%
50,825
+111
+0.2% +$7.72K
VEU icon
162
Vanguard FTSE All-World ex-US ETF
VEU
$68.5B
$3.6M 0.03%
75,536
-2,469
-3% -$111K
REYN icon
163
Reynolds Consumer Products
REYN
$5.59B
$3.6M 0.03%
+103,484
New +$3.37M
NHC icon
164
National Healthcare
NHC
$3.37B
$3.57M 0.03%
56,202
+223
+0.4% +$14.9K
COST icon
165
Costco
COST
$420B
$3.48M 0.03%
11,461
+69
+0.6% +$21K
TMO icon
166
Thermo Fisher Scientific
TMO
$220B
$3.47M 0.03%
9,568
-141
-1% -$47.3K
ALE
167
DELISTED
Allete
ALE
$3.45M 0.03%
63,216
-14,179
-18% -$804K
POWI icon
168
Power Integrations
POWI
$3.6B
$3.42M 0.03%
57,828
+12,218
+27% +$642K
WST icon
169
West Pharmaceutical
WST
$24.9B
$3.39M 0.03%
14,920
-2,223
-13% -$437K
WBA
170
DELISTED
Walgreens Boots Alliance
WBA
$3.37M 0.03%
79,498
-4,351
-5% -$185K
JNPR
171
DELISTED
Juniper Networks
JNPR
$3.34M 0.03%
146,069
+2,147
+1% +$49.4K
STAG icon
172
STAG Industrial
STAG
$7.19B
$3.31M 0.02%
112,957
+1,184
+1% +$31.2K
BMY icon
173
Bristol-Myers Squibb
BMY
$132B
$3.3M 0.02%
56,170
-134
-0.2% -$8.02K
AMZN icon
174
Amazon
AMZN
$2.96T
$3.28M 0.02%
23,760
+660
+3% +$79.7K
BRK.A icon
175
Berkshire Hathaway Class A
BRK.A
$1.12T
$3.21M 0.02%
12
– –
5 6
7
8 9

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q2 2020 Portfolio in Review

As of Q2 2020, Bahl & Gaynor held 350 positions worth $13.3B, up 16% from $11.5B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bahl & Gaynor's Q2 2020 filing shows 21 new, 125 increased, 153 reduced and 21 closed positions. Its largest new stake was Otis Worldwide: 90,609 shares worth $5.15M. The largest sale was Pfizer, an estimated $79.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q2 2020 buy was Otis Worldwide: 90,609 shares worth $5.15M.
  • Bahl & Gaynor added most to Merck in Q2 2020, an estimated $72.8M increase.
  • Bahl & Gaynor's biggest Q2 2020 reduction was Pfizer, cutting an estimated $79.9M.
  • Bahl & Gaynor fully exited Interparfums in Q2 2020, selling an estimated $4.84M.
  • Bahl & Gaynor's ten largest holdings make up 32% of its $13.3B portfolio in Q2 2020.
  • Bahl & Gaynor opened 21 new positions and closed 21 in Q2 2020.
  • Bahl & Gaynor's portfolio value rose 16% quarter-over-quarter to $13.3B.

Based on Bahl & Gaynor's 13F filing for Q2 2020, filed 13 Aug 2020.